Calicin: A Promising Drug Target Or Biomarker (G881)

Calicin: A Promising Drug Target Or Biomarker

Calicin, a peptide derived from the flowers of the poppy plant, has been found to have potential as a drug target or biomarker. Calicin has been shown to have anti-inflammatory and analgesic properties, making it a promising compound for the treatment of various inflammatory disorders.

One of the main reasons for the potential of calicin as a drug is its ability to reduce inflammation. Inflammation is a natural response of the immune system, but when it becomes chronic or uncontrolled, it can lead to a range of diseases, including heart disease , cancer, and autoimmune disorders. Calicin has been shown to have anti-inflammatory effects by reducing the production of pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6.

In addition to its anti-inflammatory properties, calicin has also been shown to have pain-relieving effects. Pain can be a sign of underlying inflammation or irritation in the body, and can be difficult to manage for individuals with chronic pain. Calicin has been shown to be effective in reducing pain by blocking the transmission of pain signals from the brain to the body.

Another potential benefit of calicin as a drug is its potential to be a biomarker. Biomarkers are molecules that are produced by the body that can be used as indicators of disease or inflammation. Calicin has been shown to be produced by the body and has been found to be elevated in individuals with certain inflammatory disorders. By using calicin as a biomarker, researchers may be able to monitor the effectiveness of potential treatments for these disorders.

While the potential benefits of calicin as a drug or biomarker are promising, it is important to note that more research is needed to fully understand its effects and potential uses. Calicin has not yet been approved for use by the FDA, and more studies are needed to determine its safety and effectiveness as a drug or biomarker.

In conclusion, calicin is a peptide derived from the flowers of the poppy plant that has been found to have potential as a drug target or biomarker. Its anti-inflammatory and pain-relieving properties make it a promising compound for the treatment of various inflammatory disorders . While more research is needed to fully understand its effects, calicin is a promising compound that may have the potential to improve the health and well-being of individuals with inflammatory disorders.

Protein Name: Calicin

Functions: Possible morphogenetic cytoskeletal element in spermiogenic differentiation

The "CCIN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCIN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5 | CCL7 | CCL8 | CCM2 | CCM2L | CCN1 | CCN2 | CCN3 | CCN4 | CCN5 | CCN6 | CCNA1 | CCNA2 | CCNB1 | CCNB1IP1 | CCNB2 | CCNB2P1 | CCNB3 | CCNC | CCND1 | CCND2 | CCND2-AS1 | CCND3 | CCNDBP1 | CCNE1 | CCNE2 | CCNF | CCNG1 | CCNG2 | CCNH | CCNI | CCNI2 | CCNJ | CCNJL | CCNK | CCNL1 | CCNL2 | CCNO | CCNP | CCNQ | CCNQP1 | CCNT1 | CCNT2 | CCNT2-AS1 | CCNT2P1 | CCNY | CCNYL1 | CCNYL2 | CCP110 | CCPG1 | CCR1 | CCR10 | CCR12P | CCR2 | CCR3 | CCR4 | CCR4-NOT transcription complex | CCR5 | CCR5AS | CCR6 | CCR7 | CCR8 | CCR9 | CCRL2 | CCS | CCSAP | CCSER1 | CCSER2